About: Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.54 (-0.20%)
CTXR NASDAQ Citius Pharmaceuticals Inc
Citius Pharmaceuticals Inc share price
Atividade de preço de CTXR
Último preço
$ 0,580
Variação (24h)
0,04 USD (7,64%)
Volume
137.42K
Volume (média 4 sem.)
-
Abertura
$ 0,53
Variação do dia
$ 0,48 - $ 0,59
Fechamento anterior
$ 0,54
Último negócio
29 Oct, 3:04 pm GMT+0
Atrasado
29 Oct, 3:04 pm GMT+0
CTXR price performance
Atrasado
29 Oct, 3:04 pm GMT+0
quote.marketSignals